Efficacy of Anlotinib Combined with Pemetrexed in Maintenance Treatment of Patients with Advanced Lung Adenocarcinoma with Negative Driver Gene and PD-L1

ZHAO Zhiyuan; LI Fang; LIU Ying

doi:10.3969/j.issn.1004-437X.2022.01.008

Home>Articles>Efficacy of Anlotinib Combined with Pemetrexed in Maintenance Treatment of Patients with Advanced Lung Adenocarcinoma with Negative Driver Gene and PD-L1

DOI: 10.3969/j.issn.1004-437X.2022.01.008

Efficacy of Anlotinib Combined with Pemetrexed in Maintenance Treatment of Patients with Advanced Lung Adenocarcinoma with Negative Driver Gene and PD-L1

ZHAO Zhiyuan

LI Fang

LIU Ying

Machine-generated Keywords：

Publication Date：2022-01-15

Online Publishing Date：2026-09-12(First online date of this platform, not the publication date of the document)

Pages：5( 36-40 )

Henan Medical Research

ISSN：1004-437X

Year, Vol.(Issue)：2022,31(1)